VALLEY NATIONAL ADVISERS INC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 773411
BETHLEHEM, PA
Position in ARWR
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$16,302
+$3,762 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#428
of 490 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $1,028,190 across 22 Biotechnology names. ARWR ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,091 | $680,282 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
191 | $94,875 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
161 | $86,448 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
1,000 | $54,540 | |
| 5 | VTVT |
vTv Therapeutics Inc.
|
980 | $36,897 | |
| 6 | MRNA |
Moderna, Inc.
|
329 | $23,039 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
200 | $16,302 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
350 | $13,653 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,302 | 200 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $12,540 | 200 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $13,278 | 200 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $6 | 200 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $3,160 | 200 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2 | 200 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $3 | 200 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3 | 200 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $5,198 | 200 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $5 | 200 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $6,120 | 200 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $5,374 | 200 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8 | 200 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $6 | 200 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $6 | 200 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $6,610 | 200 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $7,042 | 200 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $9,198 | 200 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $13,260 | 200 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $12,486 | 200 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $28,987 | 350 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $23,208 | 350 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $53,711 | 700 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $30,142 | 700 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $30,233 | 700 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $20,139 | 700 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||